Trial intelligence / Profile preview

Effect of recombinant human thyrotropin on T-lymphocyte cytokines and bone metabolism in healthy subjects

2006-004980-79Phase 2Completed

Sponsor
Medical University of Vienna
Start
Mar 2007
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, single-arm trial of thyrotropin alfa, sponsored by Medical University of Vienna. Primary endpoints: Changes in T-lymphocyte cytokine production pattern and Effects on bone metabolism. Started Mar 2007; status: completed.

02

Drugs

thyrotropin alfa

Beyond the preview

Go deeper on 2006-004980-79.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004980-79.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call